Literature DB >> 24507246

Prevalence and treatment gap of active convulsive epilepsy: a large community-based survey in rural West China.

Jia Hu1, Yang Si1, Dong Zhou1, Jie Mu1, Juan Li1, Ling Liu2, Cai-Rong Zhu3, Ying Deng4, Jun He4, Ning-Mei Zhang4, Xiao-Fang Chen4.   

Abstract

PURPOSE: Active convulsive epilepsy (ACE) impacts patients greatly, especially in low-income countries where patients do not receive appropriate treatment. In the present study, we measured the prevalence and treatment gap (TG) of ACE in rural West China.
METHODS: Six rural areas in West China that have a total population of 3,541,319 were selected to conduct prevalence and TG estimates of ACE via a clue survey from 2007 to 2009. Clue survey here is a community-based screening strategy among defined population which requires employed well-trained local physicians//health workers to collect all clues available to discover/identify/recruit patients within a study period. Questionnaire-based interviews were used for the identification of ACE patients, and information was obtained during the survey. Prevalence and TG of ACE were calculated.
RESULTS: A total of 6547 patients with ACE were identified. The estimated prevalence of ACE was 1.8 per 1000 in the general population, with the prevalences in males and females determined to be 2.0 and 1.7, respectively (p<0.001). The TG in the general population was 66.3%, and it was 66.6% and 66.0% in males and females, respectively (p>0.05). The TG figures dropped with advancing age and increased above 30 years of age. Patients aged 60 years or older had the largest TG (77.8%); those with disease course less than 10 years showed a larger TG and those who experienced two to five seizures annually had a significantly larger TG (70.6%). Additionally, only 63.9% of the ACE patients included in the study were aware of the disease and had consulted a doctor.
CONCLUSIONS: There exists a large TG of ACE in West China rural areas. Majority of those ever consulted a doctor but failed to receive or adhere to an appropriate treatment program. Management including public education as well as training of local physicians were necessary to fill that gap. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Convulsive epilepsy; Prevalence; Rural community; Treatment gap

Mesh:

Year:  2014        PMID: 24507246     DOI: 10.1016/j.seizure.2014.01.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

1.  Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador.

Authors:  Oscar H Del Brutto; Bettsy Y Recalde; Robertino M Mera
Journal:  Am J Trop Med Hyg       Date:  2021-10-11       Impact factor: 3.707

2.  An epidemiological survey of epilepsy in tropical rural areas of China.

Authors:  Guoxian Zheng; Futao Li; Yongmin Chen; Huijuan Liu; Shurong Wang; Jitong Lao; Shuang Chen; Yimin Zhang; Rui Lu; Xiaoping Liao; Lin Ma; Qifu Li
Journal:  Epilepsia Open       Date:  2021-03-02

3.  Efficacy of Phenobarbital and Prognosis Predictors in Women With Epilepsy From Rural Northeast China: A 10-Year Follow-Up Study.

Authors:  Chaojia Chu; Nan Li; Rui Zhong; Danyang Zhao; Weihong Lin
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

4.  [Epidemiological study of infantile epilepsy incidence density among infants under 36 months of age in Ningbo City from 2015 to 2019].

Authors:  X Y Yao; Z K Liu; N Li; R Ma; X F Zhao; L Zhang; G Z Xu; S Y Zhan; T Fang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-06-18

Review 5.  Quality of Life and Stigma in Epilepsy, Perspectives from Selected Regions of Asia and Sub-Saharan Africa.

Authors:  Warren Boling; Margaret Means; Anita Fletcher
Journal:  Brain Sci       Date:  2018-04-01

6.  Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis.

Authors:  Donger Zhang; Xia Li; Jing Ding; Xiatong Ke; Wenpei Ding; Yinan Ren; He Xu; Hongchao Li; Aixia Ma; Wenxi Tang
Journal:  Front Public Health       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.